The Potential of CRISPR/Cas9 in Hematotherapy.
Stem cells and development, 28(11): 710-711 PMID 31090512 DOI 10.1089/scd.2019.0079
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.